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SUMMARY
We report the results of the first three trials of an external quality control (EQC) programme performed in 71 laboratories executing
semen analysis in Tuscany Region (Italy). At the end of the second trial, participants were invited to attend a teaching course illus-
trating and inviting to adhere to procedures recommended by WHO (V edition). Results of the first three trials of the EQC docu-
mented a huge variability in the procedures and the results. The highest variability was found for morphology (CV above 80% for all
the trials), followed by count (CV of about 60% for all the trials) and motility (CV below 30% for all the trials). When results of sperm
count and morphology were divided according to the used method, mean CV values did not show significant differences. CV for mor-
phology dropped significantly at the third trial for most methods, indicating the usefulness of the teaching course for morphology
assessment. Conversely, no differences were observed after the course for motility and for most methods to evaluate count, although
CV values were lower at the second and third trial for the laboratories using the Burker cytometer. When results were divided accord-
ing to tertiles of activity, the lowest mean bias values (difference between each laboratory result and the median value of the results)
for count and morphology were observed for laboratories in the third tertile (performing over 200 semen analysis/year). Of interest,
mean bias values for concentration dropped significantly at the third trial for low activity laboratories. In conclusion, lack of agree-
ment of results of semen analysis in Tuscany is mainly because of the activity and the experience of the laboratory. Our study points
out the importance of participating in EQC programmes and periodical teaching courses as well as the use of WHO recommended
standardized procedures to increase precision and to allow the use of WHO reference values.
INTRODUCTION
Number, percentage and quality of motility and shape of sper-
matozoa are considered not only diagnostically significant but
sometimes even normative for assessing the fertility status of the
male. All these parameters can be evaluated by semen analysis.
However, semen analysis is very poorly predictive of the male
fertility status, mainly giving information about the status of
male genital tract and thus only indirect indications of male fer-
tility potential. Despite this fact, the diagnosis of male infertility
is quite often based only on semen analysis, that is used by
clinicians, in conjunction with analyses concerning the female
partners, for health-care decisions regarding the appropriate
assisted reproduction technique (ART) for the couple. Consider-
ing the elevated costs of ARTs, it is desirable that results of
semen analysis are as accurate and precise as possible, male
infertility is indeed becoming an epidemic problem affecting
almost 5% of the male population (Jungwirth et al., 2012).
Another epidemic condition with a similar prevalence in general
population is diabetes mellitus where evaluation of blood glyca-
emia has a normative value for diagnostic purposes (Hill et al.,
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2011) as it occurs for semen analysis in male infertility. However,
the percentage coefficient of variation (CV, the ratio between
standard deviation and the mean 9100) for testing glycaemia is
ranging from 2 to 4% (Harris et al., 1998), whereas the CV for
sperm analysis is greatly exciding 30%, according to previous
surveys (Jorgensen et al., 1997; Gandini et al., 2000; Cooper
et al., 2002).
In Tuscany, there are 71 laboratories (33 in public and 38 in
private structures) which perform about 20 000 semen analysis/
year. Although clinical examination of the male partner of infer-
tile couples is recommended by WHO clinical manual for the
management of the infertile male (Rowe et al., 2000), it is rou-
tinely performed only in a small subset of ART centres. Thus, the
diagnosis of male factor resides just in sperm analysis in most
ART centres.
In the ideal condition, each laboratory performing semen
analysis should apply the same methodology and adhere to the
same criteria for the different measurements. In theory, this con-
dition could be ensured by following the primary reference for
methods of semen analysis represented by the World Health
Organization (WHO) laboratory manuals (WHO, 1980, 1987,
1992, 1999, 2010), which provided guidelines for standardized
procedures in the last 30 years to allow comparison of data for
clinical and research purposes. In addition, adherence to stan-
dardized methods allows association of data with reference val-
ues, which have been recently revisited by WHO (Cooper et al.,
2010; WHO, 2010). The questions that arise concern whether all
the laboratories performing semen analysis in Tuscany adhere to
WHO guidelines, and, even in this case, whether results obtained
from the different technicians (even within the same laboratory)
are really comparable, considering the subjectivity of the mea-
surements. For these reasons, the necessity of external quality
control (EQC) and standardization of the procedures has been
highlighted in several studies (Neuwinger et al., 1990; Jørgensen
et al., 1997; Gandini et al., 2000; Cooper et al., 2002; Keel et al.,
2002; Palacios et al., 2012), and the last two editions of the WHO
manual (1999 and 2010) dedicated an entire Chapter to quality
assurance and quality control. EQC has the aim to detect and
possibly reduce systematic errors and variability in results. With
the exclusion of a pilot study (Gandini et al., 2000) performed
about 10 years ago and involving only 20 laboratories, in Italy
there are no EQC programmes for semen analysis. The idea of
performing an EQC for semen analysis among the Tuscany labo-
ratories came to our mind because of several variants in the
applied methods and in the reference values as could be evinced
from reports produced in different labs. Here, we report the
results of the first three trials of an EQC developed in the Tus-
cany region, thanks to funding from Tuscany government and
Azienda Ospedaliera Universitaria Careggi (AOUC) and involving
the 71 laboratories in the region that perform semen analysis.
We have also evaluated the effect of a teaching course (per-
formed between the second and the third trial) on variability in
the results and in the techniques used by the participating
laboratories.
MATERIALS ANDMETHODS
A request was sent to the 106 laboratories performing clinical
biochemistry analysis in public and private structures in Tus-
cany asking whether they were performing semen analysis and,
in this case, if they were willing to participate in an EQC trial. A
total of 71 laboratories declared to perform semen analysis (33
in public and 38 in private structures) and all of them agreed to
participate in the EQC.
Biological material for EQC programme was collected within
the semen analysis Laboratory of the Unit of Sexual Medicine
and Andrology of the University of Florence. Semen was col-
lected, after informed consent, from healthy volunteers who
underwent, before semen collection, serum analysis for detec-
tion of HIV, HBV and HCV and resulted negative for all the above
markers. Semen samples (3 samples/trial) were mixed and, after
formalin (1%, final concentration) addition and continuous gen-
tle agitation in a rotator, aliquoted in vials of 250 lL and sent to
the 71 laboratories for evaluation of sperm concentration and
percentage of normal morphology. For sperm motility assess-
ment, a DVD containing records from three different samples
(from 6 to 8 fields/sample of 20–30 sec/field) was obtained using
a digital video camera and sent to the laboratories. The images
for DVD were collected at 409magnification without any grid or
scale for calibration. Participants were instructed to assess
sperm parameters exactly as they were currently doing for their
own clinical specimens. In addition, they were requested to indi-
cate the method used to perform each analysis giving the choice
among Neubauer, Burker, Cell-Vu, Makler cytometers or other
methods (unspecified) for sperm count, manual or automatic
methods for sperm motility, Diff-Quick, Papanicolau,
May-Grunwald, Haematoxilin-Eosin, TestSimplets or others
(unspecified) staining for morphology. At the end of the first
trial, all participants were invited to a meeting to view the
results. On that occasion, the differences between the WHO IV
(1999) and V (2010) edition in evaluating sperm count, motility
and morphology were illustrated to the participants, to whom
the new manual (Italian version by Societa Italiana di Andrologia
e Medicina della Sessualita – SIAMS) was given. During the
meeting, participants were recommended to follow WHO (2010)
procedures to execute semen analysis. At the end of the second
trial, participants were invited to a teaching course, during
which they participated to a test for motility and morphology
evaluation both at the entry and at the end of the course. Details
of the methods of evaluation of the different parameters accord-
ing to the WHO V edition were illustrated during the course.
A secret code was assigned to each laboratory for data process-
ing. Results of each trial were collected by the Excel software. We
obtained a response with the results from 52, 66 and 56 laborato-
ries (of the 71 contacted), respectively, for the first, second and
third trial. At the end of each trial, results of the performance of
each laboratory were sent specifying, for each parameter, the
mean value, the standard deviation and the coefficient of varia-
tion (CV%) of all the participating laboratories and of those per-
forming the analysis with the same method of the laboratory if
used by at least 5 laboratories. In addition, histograms of the dis-
tribution, marking in bold the result of the laboratory, were
included.
Statistical analysis
Statistical analysis was performed using the programme Mic-
rocal Origin software 6.1 version (MicroCal Software Inc, North-
ampton, MA, USA, www.origin.com) to evaluate, for each
parameter, the mean, standard deviation (SD) and median val-
ues of all the results together and after grouping on the basis of
the used method for evaluating sperm count and sperm
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morphology. Differences between the mean CV and mean differ-
ence between each laboratory result and the median value of the
results expressed as percentage (from herein denominated
‘bias’) values were analysed using ANOVA followed by Bonferroni
test to take into account the multiplicity of testing, considering
statistically significant the values of p < 0.05/number of analy-
sed groups.
RESULTS
Sperm concentration
Table 1A shows the different techniques used by the partici-
pating laboratories to evaluate sperm concentration during the
three trials. The main tools used were the Makler and the Burker
cytometers. Despite recommendation, at the end of the first trial
and during the teaching course after the second trial, of using
the improved Neubauer cytometer, only few laboratories are
currently using such WHO recommended technique.
Mean CV  SD values of sperm count of the three trials are
reported in table A inserted in Fig. 1. No significant differences
were observed in mean CV values from the first to the second
and third trial. When data were divided according to the used
technique (inset B of Fig. 1), the mean CVs showed no signifi-
cant differences, although ANOVA analysis revealed a statistical
significance among the different methods (F = 2.98, p = 0.046).
A significant decrease in mean CVs was observed, at both second
and third trials respect to the first for Burker cytometer,
indicating an improvement of the performance, whereas no dif-
ferences were observed for Cell-vu, Makler and Neubauer.
We calculated the mean bias value of each trial of the labora-
tories that took part in at least 2 trials. We found that several lab-
oratories experienced a decrease in the bias value both at the
second as respect to the first (30/49, 61%) and at third as respect
Table 1 Counting chambers and staining methods used by the laboratories
participating in the EQC scheme for the evaluation of the sperm concentra-
tion (A) and the morphology (B) in the three trials. N indicates the number
of laboratories
1° Trial 2° Trial 3° Trial
N (%) N (%) N (%)
A: Concentration
Burker 12 (23.1) 16 (24.2) 13 (23.2)
Cell-vu 5 (9.6) 5 (7.5) 5 (8.9)
Neubauer 5 (9.6) 7 (10.6) 7 (12.5)
Makler 28 (53.8) 34 (51.5) 27 (48.2)
Others 2 (3.8) 4 (6.06) 4 (7.1)
Total 52 66 56
B: Morphology
Diff quick 7 (13.5) 8 (11.9) 5 (8.9)
Haematoxilin/Eosin 4 (7.7) 6 (8.9) 6 (10.7)
May-Grunwald 8 (15.4) 16 (23.8) 14 (25.0)
Papanicolau 12 (23.1) 10 (14.9) 8 (14.2)
Fresh 2 (3.8) 1 (1.4) 1 (1.8)
TestSimplets 18 (34.6) 21 (31.3) 17 (30.3)
Others 1 (1.9) 5 (7.4) 5 (8.9)
Total 52 67 56
Mean 
% CV SD
1° trial 75,14 30,71
2° trial 45,65 5,05
3° trial 59,03 22,07
Burker Cell-vu Makler Neubauer
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Figure 1 CV values of the trials for sperm count. Mean CV values of the trials (1, 2, 3) are shown according to the methods used by the participating Labora-
tories. *indicates significance (p < 0.016) within trials with the same cytometer. The inserted Table 1A reports mean  SD overall CV values for the three
trials. The inset B shows the mean CV value of the three trials for the different methods. Error bars represent SD values.
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to the second trial (33/53, 62%). Interestingly, when results were
divided according to tertiles of declared activity of the laborato-
ries (number of semen analysis performed/year, see Fig. 2 for
the distribution of laboratories activity), a significant decrease in
the bias value was found at the third trial for the laboratories
with low activity (<than 79 semen analysis/year) (Fig. 3A).
Sperm motility
All the participating laboratories declared to perform analysis
of sperm motility manually. No differences were observed
between mean CV values of percentage progressive [grade ‘a’,
speed >25 lm/sec + grade ‘b’, speed < 25 lm/sec according to
WHO manual IV Edition (WHO, 1999)], non-progressive [grade
‘c’, <5 lm/sec according to WHO manual IV Edition (WHO,
1999)] and immotile [grade ‘d’ according to WHO manual IV
Edition (WHO, 1999)] spermatozoa of the three trials (Fig. 4). The
highest CV values were observed for the non-progressive motility.
Of note, mean CV for progressive motility and immotile sperma-
tozoa was the lowest among all the parameters analysed in the
EQC scheme. We calculated the bias of the different laboratories
for percentage progressive motility, non-progressive motility and
immotile spermatozoa of the three trials. For all types of motility
there was a decrease in the mean bias value of the laboratories in
the third respect to the second trial. In particular, 34/53 (64%)
and 36/53 (67%) laboratories demonstrated an improvement,
respectively, for progressive and non-progressive motility.
Figure 3B shows the mean  SD bias values according to ter-
tiles of laboratory activity for progressive motility. The higher
bias values for progressive motility were observed for laborato-
ries of the second tertile.
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Figure 2 Activity of the different laboratories participating in the trials. Activity is expressed as number of semen analysis/year (ordinate, log scale).
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Figure 3 Bias values of the three trials in the different laboratories divided in tertiles of activity. Laboratories were divided in tertiles according to activity
(number of semen analysis/year, abscissa), and the mean bias values for each trial for sperm concentration (A), progressive sperm motility (B) and sperm
morphology (C) are reported on ordinates. *indicates significance (p < 0.016) respect to first trial for sperm concentration in the low activity tertile. °indi-
cates significance (p < 0.016) respect to the same trial of first tertile of activity for sperm concentration. Error bars represent SD values.
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Sperm morphology
Table 1B reports the different techniques used by the partici-
pating laboratories to evaluate sperm morphology during the
three trials. The most used method of evaluation resulted Test-
Simplets, followed by Papanicolau and May-Grunwald staining.
Mean  SD CV values for sperm morphology of the three tri-
als are shown in table A inserted in Fig. 5. No significant differ-
ences were present. Similarly, no differences were observed for
mean CV values when the different methods of evaluation were
considered (inset B of Fig. 5). Conversely, a significant decrease
in mean CV values was observed in the third trial respect to the
second for Papanicolau, Haematoxilin-Eosin and Testsimplet
staining. Moreover, at the third trial, CV values of Papanicolau,
Haematoxilin-Eosin and Testsimplet staining were significantly
lower respect to those of Diff-Quick.
Thirty-one of 50(62%) laboratories demonstrated a decrease in
the mean bias value in the second trial respect to the first and
26/50 (48%) in the third respect to the second. When results
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Figure 4 CV values of the trials of EQC for sperm motility. Mean CV values
of the three trials are shown according to the type of motility [a + b: pro-
gressive motility; c: non-progressive motility; d: immotile spermatozoa
according to WHO (1999)]. Error bars represent SD values.
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Figure 5 CV values of the trials of EQC for sperm morphology. Mean CV values of the trials (1, 2, 3) are shown according to the methods used by the partic-
ipating Laboratories. *indicates significance (p < 0.016) within trials with the same method. °indicates significance (p < 0.016) of Diff-Quick vs. Papanico-
lau, Haematoxilin-Eosin and TestSimplets at the same trial. The table A reports mean  SD overall CV values for the three trials. The inset B shows the mean
CV value of the three trials for the different methods. As only two laboratories performing haematoxilin-eosin participated in the first trial, the data have
been omitted. Error bars represent SD values.
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were divided according to tertiles of activity of the laboratories,
no differences in the mean bias value were present among labo-
ratories with different declared activity (Fig. 3C).
DISCUSSION
Quality assurance and external and internal quality control are
required for all types of biomedical analyses; in particular, they
are considered essential in Andrology Laboratories (WHO, 1999,
2010; Pacey, 2006) in view of the fact that results are entirely
operator dependent. EQC has the purpose to correct systematic
and random errors that can be present and arise during execu-
tion of semen analysis. In addition, EQC allows the laboratory to
have an idea of the type of errors present as well as the level of
‘certainty’ of their results (Pacey, 2006). Results of this study,
which analysed the performance of semen analysis laboratories
in the Tuscany region, demonstrate a huge variability both in the
results and in the applied procedures of the different laborato-
ries. Lack of agreement of semen analysis parameters may have
important consequences for patients and for infertile couples
undergoing ARTs, such as wrong choice of treatment modality
possibly resulting in low/absent fertilization. In addition, in Tus-
cany region, where ART are guaranteed by the regional Health
Care System, possible errors in the procedures arising from
incorrect semen analysis may result in great waste of public
money.
In general, the large variability in the results of our EQC is in
agreement with previous studies aimed at analysing the perfor-
mance of Andrology Laboratories (Matson, 1995; Jørgensen
et al., 1997; Gandini et al., 2000; Cooper et al., 2002; Alvarez
et al., 2005; Mallidis et al., 2012). Although performed in a group
of laboratories confined in a small region like Tuscany, our study
identified possible sources of variability in the results and indi-
cates possible solutions which may be of general interest.
One possible source of variability is represented by the meth-
ods used for the analyses. For sperm count, the lowest mean CV
values of the three trials, although not reaching statistical signifi-
cance, were obtained with the Neubauer cytometer (Fig. 1 inset
B), which is the recommended counting methods by WHO
(2010). Although at the first trial, mean CV values of results with
the Makler cytometer were similar to those of the Neubauer, two
considerations should be made on this result: one concerns the
higher number of laboratories using Makler (which may have
contributed to lower the mean CV value) and the second con-
cerns the fact that spermatozoa to be counted in our EQC test
are, at difference with fresh samples, immotile thus possibly
making easier the evaluation in this chamber and lowering the
variability. Although WHO discourages the use of the Makler cy-
tometer, as also pointed out by us during the teaching course
organized at the end of second trial, it remains the most used
counting method in Tuscany Laboratories.
Concerning morphology, our results indicate that the variabil-
ity is independent of the technique used to stain spermatozoa as
mean CV values for the various methods employed by the labo-
ratories were not different (inset B of Fig. 5). However, our study
evidenced, at the third trial, lower CV values for Papanicolau,
Haematoxilin-Eosin and TestSimplets respect to Diff-Quick, thus
indicating better performance for the former three methods.
However, it must be considered that, at least in case of TestSim-
plets, the high number of laboratories employing this methods
may have contributed to decrease in the CV value, and, at the
same time, the low number of laboratories using Diff-Quick to
increase it. For sure, laboratories employing Papanicolau,
Haematoxilin-Eosin and TestSimplets demonstrate to have a
benefit from the teaching course between second and third trial
(see also below). In any case, the huge variability in morphology
data even at the third trial evidences the need for standardiza-
tion of the procedures and increased adherence to WHO
recommendation.
Both at the meeting after the first trial and during the course
at the end of the second, we recommended adherence to WHO
(2010) indicating the problems arising by using uncorrected pro-
cedures. Despite this, most laboratories continued to use non-
recommended techniques (such as Makler chamber for counting
and Testsimplet slides for morphology evaluation) even at the
third trial. One important consequence is the fact that reference
values of WHO should not be used by these laboratories,
because, in case they are used, they may induce the clinician to
an incorrect diagnosis.
In case of motility assessment, the mean CV values are the
lowest respect to the other parameters. This result may be influ-
enced by the fact that the sample does not need any procedure
by the laboratory (as a DVD is sent), thus limiting errors caused
by handling of the sample.
Another important source of variability is represented by the
activity of the different laboratories. If we consider the results of
the first trial (which was not influenced by our recommendations
as in the case of second and, even more, the third one which was
preceded by a teaching course), the lowest bias values of results
were obtained, at least for morphology and concentration, in lab-
oratories of the third tertile of activity which declare to perform
over 200 semen analysis/year. This result reinforces the concept
that not only operator’s experience but also continuous practice
are important in performing semen analysis. Most importantly, it
should alarm about reliability of results from laboratories with
low activity, although, according to our results, these laboratories
showed better performances after teaching course, demonstrat-
ing commitment to ameliorate their activity.
Concerning possible solutions to decrease variability in the
results among the different Laboratories, our study confirms the
importance of teaching courses as also previously reported
(Bj€orndahl et al., 2002). The decrease in the mean CV of mor-
phology results at the third trial for most methods (Fig. 5) indeed
indicates that the teaching course performed at the end of the
second trial has been useful for evaluation of this parameter. It
must be considered, however, that, although useful, the course
was not sufficient to limit variability in the results of morphol-
ogy, as the overall average CV of the laboratories remained very
high, possibly because of the above-mentioned differences in
the methods used to determine the parameter. Although not sig-
nificantly different respect to the first and second, lower CV val-
ues were also observed, at the third trial, for sperm motility,
whereas results of sperm count were apparently unaffected by
the course. It should be noted that, although for sperm morphol-
ogy several images can be used in a teaching course, allowing a
better representation of the ‘normal’ spermatozoon according to
WHO (2010), illustrating how to evaluate sperm motility and
how to perform sperm counting may be more difficult, as only
directives on the procedures to be used can be given.
In conclusion, our study indicates that variability in the proce-
dures and laboratory activity (number of analysis performed) is
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the main sources of lack of agreement of results of semen analy-
sis in Tuscany region. Possible solutions to the problem are rep-
resented by persisting in participating in EQC programmes
(Cooper et al., 1999; Bj€orndahl et al., 2002), participating period-
ically to teaching courses and use of standardized WHO recom-
mended procedures to increase precision and to allow referring
to WHO reference values.
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